// App-Quantinova.ai

758.0 : Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictive and prognostic markers in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiation.

Researchers

Presenter

  • Shaan Dudani

Principal Investigators

  • Horia Marginean

  • Patricia A. Tang

  • Jose Gerard Monzon

  • Soundouss Raissouni

  • Timothy R. Asmis

  • Rachel Anne Goodwin

  • Joanna Gotfrit

  • Winson Y. Cheung

  • Michael M. Vickers

Medical Centers

  • Division of Medical Oncology, The Ottawa Hospital Cancer Centre and Department of Medicine, University of Ottawa, Ottawa, ON, Canada

  • Ottawa Hospital Cancer Centre, Ottawa, ON, Canada

  • Tom Baker Cancer Center - University of Calgary, Calgary, AB, Canada

  • Tom Baker Cancer Center, Calgary, AB, Canada

  • Tom Baker Cancer Center, Calgary, AB, Canada

  • National Cancer Institute of Canada Clinical Trials Group, The Ottawa Hospital, Ottawa, ON, Canada

  • Department of Medicine, The Ottawa Hospital, Ottawa, ON, Canada

  • Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada

  • University of Ottawa, Ottawa, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • C-C Motif Chemokine Ligand 20

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A